Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 11/20 | 0.47 |
| ▸ | MC4R | P32245 | 4/20 | 0.45 |
| ▸ | CCKBR | P32239 | 3/20 | 0.43 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.43 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23430108 | 0.95 | IL23R (0.51) | IL23RCCKBRKISS1R | |
| SCHEMBL23430107 | 0.95 | IL23R (0.51) | IL23RCCKBRKISS1R | |
| SCHEMBL20108524 | 0.90 | MC4R (0.46) | IL23RMC4RCCKBRKISS1RNPBWR1 | |
| SCHEMBL20108264 | 0.84 | IL23R (0.48) | IL23RCCKBRKISS1RNPBWR1 | |
| SCHEMBL20108335 | 0.84 | IL23R (0.48) | IL23RCCKBRKISS1RNPBWR1 | |
| SCHEMBL23430185 | 0.83 | IL23R (0.49) | IL23RMC4RCCKBRKISS1RNPBWR1 | |
| SCHEMBL23430291 | 0.83 | IL23R (0.48) | IL23RCCKBRKISS1R | |
| SCHEMBL23430285 | 0.83 | IL23R (0.48) | IL23RCCKBRKISS1R | |
| SCHEMBL23430117 | 0.82 | CCKBR (0.48) | IL23RCCKBRKISS1RNPBWR1 | |
| SCHEMBL20108602 | 0.82 | MC4R (0.58) | IL23RMC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163536-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | IPSEN PHARMA SAS (FR) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163536-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | MC4R, MC3R, MC1R | IL23R 420/4885MC4R 1/4885CCKBR 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.